Latest News about TAFTA

March 12, 2014-HAI Europe: Corporate interests should not trump access to medicines for EU citizens in secret TTIP negotiations

November 10, 2013-The Huffington Post: NSA Spying Scandal Roils US-EU Trade Negotiations

November 8, 2013-
The Washington Post: The New York Times endorsed a secretive trade agreement that the public can't read

November 6, 2013-
The Guardian: It's David Cameron who's rolling over for big corporations in the EU-US trade deal

October 28, 2013-
Tech Dirt: How NSA Spying on Angela Merkel May Scuttle TAFTA/TTIP Trade Agreement

October 25, 2013-
Inside US Trade: U.S., EU Struggle to Set Dates for Second Round of TTIP Negotiations

October 25, 2013-
Inside US Trade: EU Parliament Panel Adopts Data Protection Overhaul with 'Anti-FISA' Clause (wtonewstand.com)

October 24, 2013-
Spiegel Online: SPD holds free trade talks with the U.S. in question

October 23, 2013-
Tech Dirt: European Commission: ACTA is Dead, Long Live ACTA?

October 22, 2013-The Huffington Post: 'Trade' Deal Would Elevate Corporations to Equal Status with Nation States (links to huffingtonpost.com)

October 4, 2013-Global Research: The US-EU Transatlantic Free Trade Agreement (TAFTA): Bgi Business Corporate Power Grab

September 26, 2013-Tech Dirt: UK Government Study Tries to Gloss Over TAFTA/TTIP's Problems with Impossibly Precise Figures

August 9, 2013 - Mondaq: United States: TPP, TTIP, And Congress: The Elephant In The Room (links to mondaq.com)

August 8, 2013 -
The Washington Times: NSA scandal weakens U.S. in EU trade talks, matches China on data theft fears (links to washingtontimes.com)

July 15, 2013 -
V3.Co.UK: EU and US internet privacy talks continue in spite of PRISM spying scandal (links to v3.co.uk)

July 11, 2013 -
Public Citizen: TAFTA’s Trade Benefit: A Candy Bar (links to citizen.typepad.com)

July 10, 2013 -
Business World Online: The free-trade charade (links to bworldonline.com)

July 8, 2013 -
Financial Times: US and EU open talks on transatlantic trade pact (links to ft.com)

July 8, 2013 -
La Quadrature Du Net: Les négociations transatlantiques nuiront inévitablement aux libertés en ligne (links to laquadrature.net)

July 5, 2013 -
ACTA Blog: FFII Comment on TTIP: Openness and the right to participate (links to acta.ffii.org)

June 21, 2013 -
Le Huffington Post: Appel contre l'accord de libre-échange transatlantique (links to huffingtonpost.fr)

June 18, 2013
- ACTA Blog: FFII Condemns investor-to-state arbitration in trade talks with US (links to acta.ffii.org)

June 17, 2013 - Mediapart: L'accord transatlantique: le pouvoir aux multinationales (mediapart.fr)

May 31, 2013
- ACTA Blog: Vrijschrift Foundation rejects EU- US trade mandate (links to acta.ffii.org)

May 20, 2013 - National Journal: U.S. and E.U. Will Gnaw on Trade Agreement (links to nationaljournal.com)

For older news, visit the TAFTA news archive

 

 

Trans-Atlantic Free Trade Agreement (TAFTA)


The US and EU hold the world’s largest bilateral economic partnership. As recognized by the OECD, this alignment of economic power is seen by industry and government representatives as an opportunity to set what they consider a “gold standard” for IP rules which, over time, developing countries will most likely be pressed to adopt.

Consumers should not be excluded from secretive negotiations that can compromise access to health, cultural participation, and free expression. Because the inclusion of IP in TAFTA would likely result in political compromises that fail to adequately account for consumer interests, 45 civil society organizations from the US and EU have signed a Civil Society Declaration asking negotiators to keep IP Out of TAFTA.



Leaked Texts


LEAKED!: European Commission's initial position papers on TTIP

nitial position papers on: Regulatory Issues - Cross-Cutting Disciplines and Institutional Provisions; Technical Barriers to Trade; Regulatory Cluster: automotive sector, chemicals, pharmaceuticals; Sanitary and Phytosanitary issues (SPS); Trade and Sustainable Development; Anti-Trust & Mergers, Government Influence and Subsidies; Trade and Investment in Raw Materials and Energy. - See more at: http://www.iatp.org/documents/european-commissions-initial-position-papers-on-ttip#sthash.UQw3S1Js.dpuf
European Commission's initial position papers on TTIP - See more at: http://www.iatp.org/documents/european-commissions-initial-position-papers-on-ttip#sthash.UQw3S1Js.dpuf
European Commission's initial position papers on TTIP - See more at: http://www.iatp.org/documents/european-commissions-initial-position-papers-on-ttip#sthash.UQw3S1Js.dpuf
European Commission's initial position papers on TTIP - See more at: http://www.iatp.org/documents/european-commissions-initial-position-papers-on-ttip#sthash.UQw3S1Js.dpuf


European Commission's initial position papers on TTIP - See more at: http://www.iatp.org/documents/european-commissions-initial-position-papers-on-ttip#sthash.UQw3S1Js.dpuf

LEAKED!: "Restricted" European Commission Recommendation for a Council Decision authorising the opening of negotiations on a comprehensive trade and investment agreement, called the Transatlantic Trade and Investment Partnership, between the European Union and the United States of America


PC Documents



Press Release:
Winners of ACTA and SOPA Battles Call for Exclusion of ‘Intellectual Property’ From EU-U.S. Trade Talks  

Blog post on TAFTA: First SOPA then ACTA, now TAFTA- here we go again

See Civil Society Declaration asking negotiators to keep IP Out of TAFTA.

See Presentation "IP Out of TAFTA" by Dr. Burcu Kilic, Global Access to Medicines Program                       

See Presentation "Confidential Commercial Information vs. Our Right to Know" by Peter Maybarduk, Global Access to Medicines Program

See Video of Global Access to Medicines Program Director Peter Maybarduk's presentation at the Transatlantic Consumer Dialogue event on IP in TAFTA (June 2014)


Other Documents

EU-letter to US on handling of documents (explaining EU secrecy practices)     
US-EU Civil societies send letter to heads of state on disapproval of TAFTA and its secretive handling

                                                                                                               

10 Reasons Why Intellectual Property (IP) Should Be Kept Out of the Trans-Atlantic Free Trade Agreement  (TAFTA or T-TIP)

 

1. The European Parliament voted overwhelmingly against the ACTA in 2012.
2.
Making genes patentable would raise the cost of diagnostic tests and cancer research.        
3. Making medical procedures patentable would raise the cost of healthcare services.
4.
Harmonizing regulatory exclusivity could result in longer pharmaceutical monopolies. 
5.
Linking pharmaceutical patents to regulatory approval would impede generic competition.
6.
Imposing indirect infringement liability on ISPs would significantly raise the costs of providing internet services that facilitate freedom of speech and access to information.
7.
Strict compliance with the copyright three-step test would raise costs for consumers.
8. Protecting facts in databases would inhibit access to knowledge.
9. Requiring libraries to pay lending royalties would inhibit access to culture and knowledge.
10.
Harmonizing approaches to geographical indications (GIs) would be near impossible.



The US and EU have conflicting policies in many realms of IP. Each party supports more stringent policies in certain realms. There is a considerable risk that substantive IP negotiations may lead to worse anti-consumer standards in both the US and EU.  An IP chapter in TAFTA would essentially serve as a forum for powerful lobbies in the US and EU to continue pushing for maximalist global IP standards that fail to account for the public interest.

 

Click Here to view the full detailed 10 reasons why IP should not be included in TAFTA

For a pdf version of this document with linked sources: 10 Reasons why IP should not be included in TAFTA




Back to Access to Medicines Page

Copyright © 2014 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.